tetracyclines

Recent Rosacea Blog Posts

Sarecycline for acne and rosacea

I don’t know if rosacea sufferers really need another tetracycline variant, but Allergan has published some promising Phase III trial data for Sarecycline as a treatment for the lesions of moderate to severe acne. Whilst no longer being directly promoted as a treatment for rosacea (and indeed it is not clear if Allergan will be […]

Continue Reading

The New York Times is reporting on the health status of the President, based on an interview with his doctor – Harold N. Bornstein. The interview includes mention that Trump is taking a long acting tetracycline to control his rosacea. It isn’t clear which formulation of tetracycline this would refer to. I’m sure the reporting is […]

Continue Reading

Rosacea means 2x Parkinson’s – not so fast !

Proving once again that you shouldn’t rely on the mainstream media for your health news, blanket coverage today for a Danish statistical population study that uses the words Rosacea and Parkinson’s in the title. Even simply using the two words in the same headline implies some kind of link – reading the details of the […]

Continue Reading

Promius Pharma, a subsidiary of Dr. Reddy’s Laboratory has filed a New Drug Application for a modified release tetracycline for the treatment of rosacea. Promius is calling their new drug DFD-09. Promius Pharma is probably best know to rosacea sufferers via the availability of Promiseb Topical Cream in the US. Promiseb, a treatment for seborrheic […]

Continue Reading

Solodyn with and without Finacea

A recent study has highlighted the benefits of the combination therapy of Solodyn and Finacea. Solodyn is one of the lesser known systemic rosacea treatments. What is Solodyn? Solodyn is an extended-release, low dosage of Minocycline, a member of the tetracycline family. Solodyn is available in 8 strengths. Yes that is right you can get […]

Continue Reading

 

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.